Synopsis of recent research by authors named "Sigi Kay"
- Sigi Kay's recent research focuses on the enhancement of CAR-T cell therapies, particularly in patients with large B-cell lymphoma, seeking to improve patient outcomes through the addition of nivolumab in a prospective interventional study.
- The author has developed novel methodologies, such as a highly sensitive microscopy technique for evaluating circulating lymphocyte morphology and a consensus protocol to standardize measurable residual disease analysis in multiple myeloma, aiming to improve diagnostic capabilities.
- Kay's work also includes studies on the immunogenicity and safety of COVID-19 vaccines in patients with impaired B-cell reconstitution after cellular therapies, highlighting the challenges and potential solutions in managing post-transplant complications.